104 related articles for article (PubMed ID: 23509314)
1. Regression of liver metastases after treatment with oxaliplatin/capecitabine and development of a progressive multifocal leukoencephalopathy in a patient with advanced thymoma.
Heine A; Schmiedel A; Menschik T; Held SA; Erdmann C; Brossart P
J Clin Oncol; 2013 Apr; 31(12):e203-5. PubMed ID: 23509314
[No Abstract] [Full Text] [Related]
2. Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study.
Mohammed TA; Dennie T; Holen KD
Clin Adv Hematol Oncol; 2011 Jun; 9(6):492-500. PubMed ID: 21841751
[No Abstract] [Full Text] [Related]
3. Intrahepatic and systemic therapy with oxaliplatin combined with capecitabine in patients with hepatic metastases from breast cancer.
Nielsen DL; Nørgaard H; Vestermark LW; Pfeiffer P; Jensen BK; Nelausen KM; Bergenfeldt M; Hermann KL; Jensen BV
Breast; 2012 Aug; 21(4):556-61. PubMed ID: 22672848
[TBL] [Abstract][Full Text] [Related]
4. Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer.
Karacetin D; Yalcin B; Okten B; Ozturk S; Maral O; Incekara O
J BUON; 2009; 14(4):605-8. PubMed ID: 20148449
[TBL] [Abstract][Full Text] [Related]
5. Stage IB malignant thymoma in a Lynch syndrome patient with multiple cancers: response to incidental administration of oxaliplatin and 5-fluorouracil.
Tampellini M; Alabiso I; Sculli CM; Barberis M; Giachino D; Berruti A; Dogliotti L
J Chemother; 2006 Aug; 18(4):433-6. PubMed ID: 17024802
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX.
Klinger M; Tamandl D; Eipeldauer S; Hacker S; Herberger B; Kaczirek K; Dorfmeister M; Gruenberger B; Gruenberger T
Ann Surg Oncol; 2010 Aug; 17(8):2059-65. PubMed ID: 20177795
[TBL] [Abstract][Full Text] [Related]
7. Complete remission of unresectable colon cancer after preoperative chemotherapy selected by adenosine triphosphate-based chemotherapy response assay.
Huh JW; Park YA; Jung EJ; Lee KY; Kwon JE; Sohn SK
J Korean Med Sci; 2008 Oct; 23(5):916-9. PubMed ID: 18955806
[TBL] [Abstract][Full Text] [Related]
8. [Chemoembolization of liver metastasis].
Nørgaard H
Ugeskr Laeger; 2012 Mar; 174(12):784. PubMed ID: 22433541
[No Abstract] [Full Text] [Related]
9. [An advanced invasive thymoma that responded remarkably to neoadjuvant chemotherapy with carboplatin, adriamycin, and etoposide].
Bando S; Ikeda T; Yamanouchi H; Ohnishi T; Yamaji Y; Fujita J; Takahara J; Maeda M
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Oct; 33(10):1135-40. PubMed ID: 8544388
[TBL] [Abstract][Full Text] [Related]
10. [Oxaliplatin combined with capecitabine as first-line chemotherapy for patients with advanced gastric cancer].
Dong NN; Wang MY; Zhang Q; Liu ZF
Ai Zheng; 2009 Apr; 28(4):412-5. PubMed ID: 19622303
[TBL] [Abstract][Full Text] [Related]
11. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.
Fernández-Martos C; Pericay C; Aparicio J; Salud A; Safont M; Massuti B; Vera R; Escudero P; Maurel J; Marcuello E; Mengual JL; Saigi E; Estevan R; Mira M; Polo S; Hernandez A; Gallen M; Arias F; Serra J; Alonso V
J Clin Oncol; 2010 Feb; 28(5):859-65. PubMed ID: 20065174
[TBL] [Abstract][Full Text] [Related]
12. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.
Tamandl D; Klinger M; Eipeldauer S; Herberger B; Kaczirek K; Gruenberger B; Gruenberger T
Ann Surg Oncol; 2011 Feb; 18(2):421-30. PubMed ID: 20844968
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy or no chemotherapy in clear margins after neoadjuvant chemoradiation in locally advanced rectal cancer: CHRONICLE. A randomised phase III trial of control vs. capecitabine plus oxaliplatin.
Glynne-Jones R; Meadows H; Wood W
Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):327-9. PubMed ID: 17434299
[No Abstract] [Full Text] [Related]
14. [End results of combined treatment in metastatic colorectal cancer].
Polysalov VN; Rutkin IO; Krotova OA; Tlostanova MS
Vopr Onkol; 2011; 57(2):265-9. PubMed ID: 21809678
[No Abstract] [Full Text] [Related]
15. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer.
Rödel C; Liersch T; Hermann RM; Arnold D; Reese T; Hipp M; Fürst A; Schwella N; Bieker M; Hellmich G; Ewald H; Haier J; Lordick F; Flentje M; Sülberg H; Hohenberger W; Sauer R
J Clin Oncol; 2007 Jan; 25(1):110-7. PubMed ID: 17194912
[TBL] [Abstract][Full Text] [Related]
16. Capecitabine plus oxaliplatin for the treatment of colorectal cancer.
Carrato A; Gallego-Plazas J; Guillén-Ponce C
Expert Rev Anticancer Ther; 2008 Feb; 8(2):161-74. PubMed ID: 18279056
[TBL] [Abstract][Full Text] [Related]
17. Patients with locally advanced and metastatic colorectal cancer treated with capecitabine versus 5-fluorouracil as monotherapy or combination therapy with oxaliplatin: a cost comparison.
Chu E; Schulman KL; McKenna EF; Cartwright T
Clin Colorectal Cancer; 2010 Oct; 9(4):229-37. PubMed ID: 20920995
[TBL] [Abstract][Full Text] [Related]
18. Case records of the Massachusetts General Hospital. Case 16-2007. A 61-year-old man with a mediastinal mass.
Wright CD; Fidias P; Choi NC; Shepard JA; Hasserjian RP
N Engl J Med; 2007 May; 356(21):2185-93. PubMed ID: 17522403
[No Abstract] [Full Text] [Related]
19. Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial.
Díaz-Rubio E; Tabernero J; Gómez-España A; Massutí B; Sastre J; Chaves M; Abad A; Carrato A; Queralt B; Reina JJ; Maurel J; González-Flores E; Aparicio J; Rivera F; Losa F; Aranda E;
J Clin Oncol; 2007 Sep; 25(27):4224-30. PubMed ID: 17548839
[TBL] [Abstract][Full Text] [Related]
20. Plasma disposition of capecitabine (CCB) and its metabolites 5'-deoxy-5-fluorocytidine (5'-DFCR) and 5'-deoxy-5-fluorouracil (5'-DFUR) with two different capecitabine/oxaliplatin dosage regimens.
Farkouh A; Schueller J; Scheithauer W; Czejka M
Int J Clin Pharmacol Ther; 2010 Jul; 48(7):487-8. PubMed ID: 20557855
[No Abstract] [Full Text] [Related]
[Next] [New Search]
